| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |